Literature DB >> 18687805

Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine-rich protein 61.

Colin T Walsh1, Julie Radeff-Huang, Rosalia Matteo, Albert Hsiao, Shankar Subramaniam, Dwayne Stupack, Joan Heller Brown.   

Abstract

A subset of G-protein coupled receptors (GPCRs), including the thrombin receptor (PAR1), elicits mitogenic responses. Thrombin also activates Ras homolog gene family member A (RhoA) and activating protein (AP-1) -mediated gene expression in 1321N1 astrocytoma cells, whereas the nonmitogenic agonist carbachol does not. Transcriptomic analysis was used to explore differential gene induction by these agonists and revealed that the matricellular protein cysteine-rich 61 (Cyr61/CCN1) is selectively induced by thrombin. The ability of GPCR agonists to induce Cyr61 parallels their ability to activate RhoA; agonist-stimulated Cyr61 expression is inhibited by C3 toxin. When Cyr61 is down-regulated using short interfering RNA (siRNA) or short-hairpin RNA (shRNA), thrombin-induced DNA synthesis is significantly attenuated. When Cyr61 expression is induced, it appears in the extracellular compartment and on the cell surface. Extracellular Cyr61 interacts with alpha(5), alpha(6), and beta(1) integrins on these cells, and monoclonal antibodies directed against alpha(5) and beta(1) integrins inhibit thrombin-induced DNA synthesis. Functional blockade of Cyr61 with soluble heparin or anti-Cyr61 antibodies also inhibits thrombin-induced DNA synthesis. Thus Cyr61 is a highly inducible, secreted extracellular factor through which GPCR and RhoA signaling pathways engage integrins that contribute to GPCR-mediated proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687805      PMCID: PMC3980657          DOI: 10.1096/fj.08-113266

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  76 in total

1.  Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas.

Authors:  Dong Xie; Dong Yin; He-Jing Wang; Gen-Tao Liu; Robert Elashoff; Keith Black; H Phillip Koeffler
Journal:  Clin Cancer Res       Date:  2004-03-15       Impact factor: 12.531

2.  Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.

Authors:  Takayuki Yamada; Koichi Sato; Mayumi Komachi; Enkhzol Malchinkhuu; Masayuki Tobo; Takao Kimura; Atsushi Kuwabara; Yasuhiro Yanagita; Toshiro Ikeya; Yoshifumi Tanahashi; Tetsushi Ogawa; Susumu Ohwada; Yasuo Morishita; Hideo Ohta; Doon-Soon Im; Koichi Tamoto; Hideaki Tomura; Fumikazu Okajima
Journal:  J Biol Chem       Date:  2003-12-03       Impact factor: 5.157

3.  Regulation of Cyr61/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways.

Authors:  Ji-Soo Han; Edward Macarak; Joel Rosenbloom; Kwang Chul Chung; Brahim Chaqour
Journal:  Eur J Biochem       Date:  2003-08

4.  The rho gene product expressed in E. coli is a substrate of botulinum ADP-ribosyltransferase C3.

Authors:  K Aktories; U Braun; S Rösener; I Just; A Hall
Journal:  Biochem Biophys Res Commun       Date:  1989-01-16       Impact factor: 3.575

5.  Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion.

Authors:  Michelle A Booden; Lynn B Eckert; Channing J Der; JoAnn Trejo
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

6.  Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells.

Authors:  Ningyu Chen; Shr-Jeng Leu; Viktor Todorovic; Stephen C-T Lam; Lester F Lau
Journal:  J Biol Chem       Date:  2004-08-10       Impact factor: 5.157

7.  The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis.

Authors:  Maria Julia Marinissen; Mario Chiariello; Tamara Tanos; Ora Bernard; Shuh Narumiya; J Silvio Gutkind
Journal:  Mol Cell       Date:  2004-04-09       Impact factor: 17.970

8.  Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61).

Authors:  Shr-Jeng Leu; Ying Liu; Ningyu Chen; Chih-Chiun Chen; Stephen C-T Lam; Lester F Lau
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

9.  Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.

Authors:  Dong Xie; Dong Yin; Xiangjun Tong; James O'Kelly; Akio Mori; Carl Miller; Keith Black; Dorina Gui; Johathan W Said; H Phillip Koeffler
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

10.  Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.

Authors:  Shinji Sakamoto; Masahiro Yokoyama; Xianghua Zhang; Kulkarni Prakash; Kaori Nagao; Takashi Hatanaka; Robert H Getzenberg; Yoshiyuki Kakehi
Journal:  Endocrinology       Date:  2004-02-26       Impact factor: 4.736

View more
  24 in total

Review 1.  CCN1/CYR61: the very model of a modern matricellular protein.

Authors:  Lester F Lau
Journal:  Cell Mol Life Sci       Date:  2011-07-31       Impact factor: 9.261

Review 2.  G Protein-Coupled Receptor and RhoA-Stimulated Transcriptional Responses: Links to Inflammation, Differentiation, and Cell Proliferation.

Authors:  Olivia M Yu; Joan Heller Brown
Journal:  Mol Pharmacol       Date:  2015-04-22       Impact factor: 4.436

3.  Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs).

Authors:  Jung-Soon Mo; Fa-Xing Yu; Rui Gong; Joan Heller Brown; Kun-Liang Guan
Journal:  Genes Dev       Date:  2012-09-12       Impact factor: 11.361

4.  The matricellular protein Cyr61 is a key mediator of platelet-derived growth factor-induced cell migration.

Authors:  Fuqiang Zhang; Feng Hao; Dong An; Linlin Zeng; Yi Wang; Xuemin Xu; Mei-Zhen Cui
Journal:  J Biol Chem       Date:  2015-01-26       Impact factor: 5.157

5.  The Ras-related protein, Rap1A, mediates thrombin-stimulated, integrin-dependent glioblastoma cell proliferation and tumor growth.

Authors:  Jacqueline Sayyah; Alena Bartakova; Nekeisha Nogal; Lawrence A Quilliam; Dwayne G Stupack; Joan Heller Brown
Journal:  J Biol Chem       Date:  2014-05-01       Impact factor: 5.157

6.  The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus.

Authors:  K Fujii; K Kurozumi; T Ichikawa; M Onishi; Y Shimazu; J Ishida; E A Chiocca; B Kaur; I Date
Journal:  Cancer Gene Ther       Date:  2013-07-05       Impact factor: 5.987

Review 7.  Caught between a "Rho" and a hard place: are CCN1/CYR61 and CCN2/CTGF the arbiters of microvascular stiffness?

Authors:  Brahim Chaqour
Journal:  J Cell Commun Signal       Date:  2019-08-02       Impact factor: 5.782

Review 8.  G protein-coupled receptors go extracellular: RhoA integrates the integrins.

Authors:  Colin T Walsh; Dwayne Stupack; Joan Heller Brown
Journal:  Mol Interv       Date:  2008-08

9.  ERK1/2 signaling dominates over RhoA signaling in regulating early changes in RNA expression induced by endothelin-1 in neonatal rat cardiomyocytes.

Authors:  Andrew K Marshall; Oliver P T Barrett; Timothy E Cullingford; Achchuthan Shanmugasundram; Peter H Sugden; Angela Clerk
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

10.  Genomic and phenotypic analysis reveals a key role for CCN1 (CYR61) in BAG3-modulated adhesion and invasion.

Authors:  Jareer N Kassis; Victoria M Virador; Elizabeth A Guancial; Daniel Kimm; Allen S Ho; Mark Mishra; Eric Y Chuang; John Cook; David Gius; Elise C Kohn
Journal:  J Pathol       Date:  2009-08       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.